| |
|
|
|
Hemispherx Biopharma Inc.  
|
|
0.145 -0.002 (-0.01%) |
04-18 15:58 |
|
Open: |
0.1425 |
Pre close: |
0.147 |
Target:
|
0.23
|
|
High: |
0.1505 |
Low: |
0.1402 |
Resistance:
|
0.20
0.23
|
|
Volume: |
1,190,569 |
Market Cap: |
9M |
Support:
|
0.14
0.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.15
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.16 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.19 |
Stochastic Oscillator |
%K(14,3):
|
9.19 |
|
MA(250): |
0.24 |
%D(3): |
11.70 |
|
Average Volume(K) |
3-Month: |
112496
|
52-Week |
High:
|
0.37 |
|
10-Days: |
422555 |
Low: |
0.14 |
|
RSI |
RSI(14):
|
40.05 |
Change(%): |
-59.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-142.3 |
Shares Out. (M) |
62.29 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-70.3 |
Shares Float (M) |
58.46 |
|
EPS Est. Next Year |
-0.030 |
PEG Ratio |
-0.03 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
380.0 |
% Held by Institutions |
3.40 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
204 |
|
Book Value (p.s.) |
1.810 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.08 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.64 |
P/S |
901959232.00 |
|
Operating Margin |
-3121.25 |
Levered Free Cash Flow
(M) |
-7.17 |
P/CF |
-0.85 |
|
|
|
|
|
|
